Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Hunterdon Medical Center and The Institute for Advanced Reconstruction Become the First on the East Coast to Implement Lumicell® Precision Guided Breast Cancer Surgery


News provided by

The Institute for Advanced Reconstruction

Sep 12, 2025, 13:54 ET

Share this article

Share toX

Share this article

Share toX


Dr. Jennifer Montes and Dr. Zuhaib Ibrahim Lead Collaborative, Oncoplastic Approach Using Groundbreaking Intraoperative Imaging Technology

FLEMINGTON, N.J., Sept. 12, 2025 /PRNewswire-PRWeb/ -- Hunterdon Medical Center and The Institute for Advanced Reconstruction proudly announce being the first healthcare providers on the East Coast to use the Lumicell® Direct Visualization System for breast cancer surgery — a cutting-edge advancement that enables surgeons to detect residual cancer cells in "real time" during surgery.

This milestone was achieved through the collaborative efforts of Dr. Jennifer Montes, Director of the Breast Program at Hunterdon Medical Center, and Dr. Zuhaib Ibrahim, a board-certified plastic and reconstructive surgeon at The Institute for Advanced Reconstruction with specialized training in aesthetic and microsurgical reconstruction. Together, they are integrating Lumicell into oncoplastic breast-conserving procedures, offering patients a highly sophisticated approach that enhances both cancer clearance and cosmetic outcomes.

"This partnership allows us to treat breast cancer with an unprecedented level of precision — both oncologically and aesthetically," said Dr. Ibrahim.

Post this

"Our ability to identify and remove microscopic residual disease before the patient even leaves the operating room is nothing short of revolutionary," said Dr. Montes. "When combined with advanced reconstructive techniques, this technology allows us to achieve clear margins without compromising the aesthetic result."

Lumicell is a first-in-class intraoperative imaging platform designed to identify residual cancer at the margins of the surgical cavity — during surgery — when it matters most. The system includes:

  • LUMISIGHT™ Imaging Agent – a fluorescent agent that accumulates in cancer cells.
  • LUM System™ Handheld Imaging Device – used to scan the tumor bed and visualize microscopic disease.
  • Decision-Making Software – provides real-time data to guide further tissue resection if needed.

With Lumicell, surgeons can confidently assess whether additional tissue should be removed, dramatically reducing the need for reoperations due to positive margins — a common and distressing scenario in breast-conserving therapy.

Dr. Jennifer Montes and Dr. Zuhaib Ibrahim lead the breast surgical oncology and plastic surgery teams at Hunterdon Medical Center, where they are pioneering advanced oncoplastic approaches to breast cancer care.

Dr. Montes, a board-certified breast surgeon and Director of the Breast Program, trained at Lenox Hill Hospital and completed her breast surgery fellowship at NYU. She brings over a decade of experience in breast-conserving surgery and interventional breast procedures and is the founder of Evolve Pink, a nonprofit dedicated to survivorship and empowerment.

Dr. Ibrahim, Director of Plastic and Reconstructive Surgery, is board-certified and trained at Johns Hopkins and Penn State. He is internationally recognized for his work in breast reconstruction and peripheral nerve surgery, including contributing to the first bilateral arm transplant in a quadruple amputee. At Hunterdon, he introduced state-of-the-art techniques such as DIEP flap reconstruction, expanding access to aesthetic, reconstructive options for patients in the region.

Together, Drs. Montes and Ibrahim are setting a new standard for patient-centered, technology-driven, and aesthetically focused breast cancer care.

"This partnership allows us to treat breast cancer with an unprecedented level of precision — both oncologically and aesthetically," said Dr. Ibrahim. "By combining the powerful imaging capabilities of Lumicell with oncoplastic reconstruction, we're redefining what's possible in breast-conserving surgery. Patients benefit from fewer reoperations, better outcomes, and the confidence that comes with personalized, state-of-the-art care."

By implementing Lumicell and fostering this level of interdisciplinary collaboration, Hunterdon Medical Center is raising the bar for community-based cancer care — offering patients access to state-of-the-art technology and aesthetic-conscious surgery close to home.

To learn more about Hunterdon Medical Center, visit: https://www.hunterdonhealth.org/locations/hunterdon-medical-center

To learn more about The Institute for Advanced Reconstruction, visit: https://advancedreconstruction.com

Media Contact

Ed Cunning, The Institute for Advanced Reconstruction, 1 8482722772, [email protected], https://www.advancedreconstruction.com/

SOURCE The Institute for Advanced Reconstruction

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.